In vivo and in vitro binding of 2,4-dichlorophenoxyacetic acid to a rat liver mitochondrial protein

被引:15
作者
Di Paolo, O [1 ]
de Duffard, AME [1 ]
Duffard, R [1 ]
机构
[1] Univ Nacl Rosario, Sch Biochem & Pharmaceut Sci, Expt Toxicol Lab, RA-2000 Rosario, Santa Fe, Argentina
关键词
adduct; covalent interaction; phenoxyherbicides; 2,4-dichlorophenoxyacetic acid (2,4-D); mitochondrial proteins;
D O I
10.1016/S0009-2797(01)00255-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2.4-Dichlorophenoxyacetic acid (2,4-D) is a hormonal herbicide widely used in the world because of its efficacy in the control of broadleaf and woody plants. In this study we have demonstrated in vivo covalent binding of the phenoxyherbicide 2,4-D to a single protein of 52 kD (from rat liver mitochondrial preparation) detected through immunoblotting studies with the specific antiserum for 2.4-D. The direct involvement of 2,4-D in the formation of the adduct has also been demonstrated in vitro, using liver mitochondrial preparations exposed to C-14-UL-2,4-D. Radiolabeled protein separated by SDS-PAGE and afterwards electroeluted showed a single labeled protein of 52 kD. When mitochondria exposed to radiolabeled xenobiotic were devoid of their outer membrane, the specific activity observed suggest that protein involved in covalent interaction belongs to the inner mitochondrial membrane, We propose that covalent binding of the phenoxyherbicide 2,4-D to a very specific single protein of 52 kD observed in vitro and in vivo may be related to known alterations of the mitochondrial function. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:229 / 241
页数:13
相关论文
共 36 条
[11]   BIOCHEMICAL-ALTERATIONS IN SKELETAL-MUSCLE INDUCED BY 2,4-DICHLOROPHENOXYACETIC BUTYL ESTER DURING CHICK EMBRYONIC-DEVELOPMENT [J].
DUFFARD, RO ;
ARGUELLO, JM ;
DEDUFFARD, AME .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (11) :2433-2440
[12]   THE POSSIBLE CELLULAR MECHANISM OF 2,4-DICHLOROPHENOXYACETATE-INDUCED MYOPATHY [J].
DUX, E ;
TOTH, I ;
DUX, L ;
JOO, F ;
KISZELY, G .
FEBS LETTERS, 1977, 82 (02) :219-222
[13]  
EISEMAN J, 1984, 2184104 HAZL LAB AM
[14]  
ENGUAL E, 1972, J IMMUNOL, V109, P129
[15]  
ERNE K, 1966, ACTA VET SCAND, V7, P240
[16]  
HINSON JA, 1992, ANNU REV PHARMACOL, V32, P471, DOI 10.1146/annurev.pa.32.040192.002351
[17]  
HORROCKS DL, 1974, APPLICATIONS LIQUID, P72
[18]  
JOHNSON D, 1967, METHOD ENZYMOL, V10, P95
[19]  
KAPLAN RS, 1986, J BIOL CHEM, V261, P2767
[20]  
KIM S, 1996, BIOCHEMISTRY-US, P445